subject: CHEBI:72690

subject_name: Pomalidomide

object_name: Recurrent Primary Central Nervous System Neoplasm


subject: CHEBI:72690

object_name: Refractory Primary Central Nervous System Neoplasm

tested_intervention: yes


subject: CHEBI:72690

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:72690

object_name: Recurrent Childhood Visual Pathway Glioma


subject: CHEBI:72690

object_name: neurofibromatosis 1


subject: CHEBI:72690

object_name: neurofibromatosis type 1


subject: CHEBI:135919

subject_name: Nesiritide

object_name: Syncope Related to COVID-19

tested_intervention: unsure


subject: CHEBI:135919

object_name: Syncope, CTCAE 5.0


subject: CHEBI:135919

object_name: Syncope


subject: CHEBI:16348

subject_name: Bovinocidin


subject: CHEBI:16348


subject: CHEBI:16348


subject: CHEBI:80234

subject_name: Brain natriuretic peptide


subject: CHEBI:80234


subject: CHEBI:80234


subject: UNII:F2D5P81X82

object_name: Acute Ischemic Stroke


subject: UNII:F2D5P81X82

object_name: Ischemic stroke


subject: DRUGBANK:DB15422


subject: DRUGBANK:DB15422


subject: UMLS:C5417886

object_name: pancreatic neoplasm


subject: UMLS:C5417886

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5417886

object_name: malignant pancreatic neoplasm


subject: CHEBI:600103

subject_name: daptomycin

object_name: staphylococcal infection


subject: CHEBI:600103

object_name: Staphylococcal Skin Infections


subject: CHEBI:4974

subject_name: Famciclovir

object_name: herpes simplex


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Neuromuscular inhibition


subject: CHEBI:6456

object_name: Neuromuscular block, function


subject: UNII:2P3VWU3H10

subject_name: ACTIVATED CHARCOAL

object_name: COPD, severe early onset


subject: UNII:2P3VWU3H10

object_name: chronic obstructive pulmonary disease


subject: CHEBI:27594

subject_name: Graphite


subject: CHEBI:27594


subject: CHEBI:9927

subject_name: Valsartan

object_name: nephrotic syndrome


subject: CHEBI:9927

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:94534

subject_name: olanzapine

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:94534

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:7862

subject_name: Oxymetazoline

object_name: middle ear disorder


subject: CHEBI:7862

object_name: Atopic rhinitis


subject: CHEBI:58432

subject_name: histaminium


subject: CHEBI:58432


subject: CHEBI:18295

subject_name: Histamine


subject: CHEBI:18295


subject: CHEBI:51209

subject_name: Pseudoephedrine


subject: CHEBI:51209


subject: UMLS:C0885067

subject_name: Ambrosia artemisiifolia homeopathic preparation


subject: UMLS:C0885067


subject: CHEBI:16302

object_name: latent tuberculosis infection


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: CHEBI:82315

object_name: Atherosclerosis of popliteal artery


subject: CHEBI:82315

object_name: Atherosclerosis of femoral artery


subject: CHEBI:82315

object_name: obstructive disease


subject: CHEBI:28435


subject: CHEBI:28435


subject: CHEBI:28435


subject: CHEBI:943

subject_name: dichlobanil


subject: CHEBI:943


subject: CHEBI:943


subject: DRUGBANK:DB14046

subject_name: Dichlorobenzene


subject: DRUGBANK:DB14046


subject: DRUGBANK:DB14046


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Infant T Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Pre T-ALL


subject: PUBCHEM.COMPOUND:596

object_name: T-cell childhood acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:596

object_name: T-cell adult acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:596

object_name: T-cell childhood lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Adult T Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: T-lymphoblastic lymphoma


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:63612

subject_name: Nelarabine


subject: CHEBI:63612


subject: CHEBI:63612


subject: CHEBI:63612


subject: CHEBI:63612


subject: CHEBI:63612


subject: CHEBI:63612


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:59204

subject_name: Carbetocin

object_name: Caesarean section


subject: CHEBI:74698

subject_name: Met-Arg

object_name: Safety Issues


subject: PR:000011407

subject_name: mineralocorticoid receptor


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: retinopathy of prematurity


subject: CHEBI:4466

object_name: exudative vitreoretinopathy 1


subject: CHEBI:4466

object_name: Retinopathy of Prematurity, AE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:64312

subject_name: Memantine

object_name: epilepsy


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: triple-negative breast carcinoma


subject: UNII:GKF8S4C432

object_name: Triple-Negative Breast Cancer Finding


subject: MESH:D053061

subject_name: Herpes Zoster Vaccine

object_name: Shingles, CTCAE


subject: CHEBI:456215

subject_name: adenosine 5'-monophosphate(2-)

object_name: herpes zoster


subject: CHEBI:456215


subject: CHEBI:28931


subject: CHEBI:28931


subject: PUBCHEM.COMPOUND:53481006

subject_name: Adenosine 2'-phosphate


subject: PUBCHEM.COMPOUND:53481006


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:28971


subject: CHEBI:16335

subject_name: Adenosine


subject: CHEBI:16335


subject: CHEBI:40050

subject_name: Amprenavir


subject: CHEBI:40050


subject: UMLS:C4084937

subject_name: Antimicrobial Peptide


subject: UMLS:C4084937


subject: UMLS:C4285220

subject_name: Absorbable Modified Polymer Hemostatic Powder


subject: UMLS:C4285220


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Blastic plasmacytoid dendritic cell neoplasm (BPDCN)


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C5237178


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Drug Interactions


subject: PUBCHEM.COMPOUND:521372

object_name: Adverse drug interaction


subject: CHEBI:184381

subject_name: Bacitracin

object_name: congenital arteriovenous fistula


subject: CHEBI:184381

object_name: Arteriovenous fistula only (in use with two needles)


subject: CHEBI:31401

subject_name: Cilostazol

object_name: Stroke (heart beat)


subject: CHEBI:31401

object_name: Stroke, CTCAE


subject: CHEBI:149504

object_name: severe acute respiratory syndrome


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Erectile dysfunction following radical prostatectomy


subject: CHEBI:231683

subject_name: Anakinra

object_name: Recurrent pericarditis


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: cancer


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: CHEBI:22652

object_name: desmoplastic small round cell tumor


subject: CHEBI:22652

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: CHEBI:22652

object_name: esophageal adenocarcinoma


subject: CHEBI:22652

object_name: lung adenocarcinoma


subject: CHEBI:22652

object_name: cervical adenocarcinoma


subject: CHEBI:22652

object_name: adenocarcinoma


subject: CHEBI:22652

object_name: bile duct adenocarcinoma


subject: CHEBI:22652

object_name: gastric adenocarcinoma


subject: CHEBI:22652

object_name: carcinoma


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783

object_name: malignant soft tissue neoplasm


subject: CHEBI:176783

object_name: sarcoma


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C1434448

object_name: astrocytic tumor


subject: UMLS:C1434448

object_name: anaplastic astrocytoma


subject: UMLS:C1434448

object_name: glioblastoma


subject: UMLS:C1434448

object_name: Brain Stem Glioblastoma


subject: UMLS:C1434448

object_name: glioma susceptibility 1


subject: UMLS:C1434448

object_name: Grade III Childhood Astrocytoma


subject: UMLS:C1434448

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C1434448

object_name: oligoastrocytoma


subject: UNII:1VZO7A0J9S

object_name: diabetic retinopathy


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: ovarian cancer


subject: UNII:M89N0Q7EQR

object_name: ovarian neoplasm


subject: UNII:M89N0Q7EQR

object_name: bladder transitional cell carcinoma


subject: UNII:M89N0Q7EQR

object_name: transitional cell carcinoma


subject: UNII:M89N0Q7EQR

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:M89N0Q7EQR

object_name: Adult Soft Tissue Sarcoma


subject: UNII:M89N0Q7EQR


subject: UNII:M89N0Q7EQR

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:M89N0Q7EQR

object_name: soft tissue sarcoma


subject: UNII:M89N0Q7EQR

object_name: synovial sarcoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379

object_name: sarcoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: Prostate Carcinoma Metastatic in the Bone


subject: CHEBI:63584

object_name: prostate adenocarcinoma


subject: CHEBI:63584

object_name: Castration Levels of Testosterone


subject: CHEBI:63584

object_name: prostate small cell carcinoma


subject: CHEBI:63584

object_name: Lymphadenopathy


subject: CHEBI:31355

subject_name: Carboplatin

object_name: castration-resistant prostate carcinoma


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: GTOPDB:12969

subject_name: tarlatamab

object_name: respiratory tract neoplasm


subject: GTOPDB:12969

object_name: neoplasm of thorax


subject: UNII:74X82ST8Q1

subject_name: TARLATAMAB


subject: UNII:74X82ST8Q1


subject: UMLS:C4687660

subject_name: AMG 757


subject: UMLS:C4687660


subject: UMLS:C0733521

subject_name: Ara-C

object_name: cancer


subject: UMLS:C0733521

object_name: neoplasm


subject: UMLS:C0733521

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C0733521

object_name: non-Hodgkin lymphoma


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: juvenile idiopathic arthritis


subject: PUBCHEM.COMPOUND:2269


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:4877

subject_name: Ethambutol

object_name: Mycobacterium avium complex disease


subject: CHEBI:4877


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: CHEBI:132922

object_name: Bone fracture


subject: CHEBI:132922

object_name: Fracture, CTCAE


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UMLS:C5205554

subject_name: AR PROTAC ARV-110

object_name: metastatic prostate carcinoma


subject: CHEBI:76004

subject_name: Dimethyl fumarate

object_name: sleep apnea


subject: CHEBI:76004

object_name: Sleep Apnea, CTCAE


subject: CHEBI:76004

object_name: obstructive sleep apnea syndrome


subject: CHEBI:72296

subject_name: Apixaban

object_name: intracerebral hemorrhage


subject: CHEBI:167656

subject_name: Brivanib alaninate

object_name: Cervix carcinoma recurrent


subject: CHEBI:167656

object_name: Persistent Disease


subject: CHEBI:167656

object_name: cervical adenocarcinoma


subject: CHEBI:167656

object_name: cervical adenosquamous carcinoma


subject: CHEBI:167656

object_name: Cervical Squamous Cell Carcinoma, Not Otherwise Specified


subject: CHEBI:8988

object_name: melanoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: UMLS:C5544680

subject_name: ensovibep


subject: CHEBI:173073


subject: CHEBI:2549

subject_name: Albuterol

object_name: myasthenia gravis


subject: CHEBI:2549

object_name: Myasthenia Gravis, CTCAE


subject: UMLS:C4329318

subject_name: Anti-CDH6 Antibody-drug Conjugate HKT288

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4329318

object_name: clear cell renal carcinoma


subject: UMLS:C4329318

object_name: renal cell adenocarcinoma


subject: UMLS:C4329318

object_name: renal cell carcinoma


subject: UMLS:C4329318

object_name: ovarian carcinoma


subject: UMLS:C4329318

object_name: malignant epithelial tumor of ovary


subject: GTOPDB:12966

subject_name: cadonilimab


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C2348756

subject_name: Testosterone Gel

object_name: arteriosclerosis disorder


subject: UMLS:C2348756

object_name: atherosclerosis


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: CHEBI:84094


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:2453

subject_name: Acyclovir

object_name: age-related macular degeneration


subject: PUBCHEM.COMPOUND:4568

subject_name: Nystatin A1


subject: CHEMBL.COMPOUND:CHEMBL5465559

subject_name: NYSTATIN


subject: CHEBI:7660

subject_name: nystatin


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:3770

subject_name: co-trimoxazole


subject: UMLS:C0041044


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: rectal cancer


subject: UMLS:C4287697


subject: CHEBI:177298

object_name: rectal neoplasm


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:9654

subject_name: Trazodone

object_name: sleep disorder


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: non-small cell lung carcinoma


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: UMLS:C5666968

subject_name: KRAS G12C Inhibitor MK-1084


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:95341

subject_name: Baricitinib

object_name: autoimmune thrombocytopenia


subject: CHEBI:95341

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:95341

object_name: autoimmune thrombocytopenic purpura


subject: PUBCHEM.COMPOUND:1971

subject_name: ent-Abacavir

object_name: hepatitis C


subject: CHEBI:421707

subject_name: Abacavir


subject: PR:000023218

subject_name: methionine import ATP-binding protein MetN


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Pleural Infection


subject: CHEBI:51254

object_name: Pleural Infection, CTCAE


subject: CHEBI:51254

object_name: pleural empyema


subject: CHEBI:51254

object_name: empyema


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:48947


subject: CHEBI:48947

object_name: Community-Acquired Pneumonia


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:28001

subject_name: Vancomycin

object_name: Wound Infection


subject: CHEBI:28001

object_name: Wound Infection, CTCAE


subject: CHEBI:28001

object_name: Physical trauma


subject: CHEBI:28001

object_name: Injury


subject: CHEBI:28001

object_name: Trauma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:135537060

subject_name: Rintatolimod


subject: UNII:94325AJ25N

subject_name: RINTATOLIMOD


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: severe sepsis with septic shock


subject: UMLS:C2825026

object_name: severe sepsis without septic shock


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:151315


subject: CHEBI:32139

object_name: Urinary Urgency


subject: CHEBI:32139

object_name: urgency urinary incontinence


subject: CHEBI:32139

object_name: Urinary incontinence


subject: CHEBI:32139

object_name: Urinary Incontinence, CTCAE 5.0


subject: CHEBI:71416

subject_name: phenazopyridine


subject: CHEBI:71416


subject: CHEBI:71416


subject: CHEBI:71416


subject: PUBCHEM.COMPOUND:135580740

subject_name: Phenazo


subject: PUBCHEM.COMPOUND:135580740


subject: PUBCHEM.COMPOUND:135580740


subject: PUBCHEM.COMPOUND:135580740


subject: UNII:K2J09EMJ52

subject_name: Phenazopyridine


subject: UNII:K2J09EMJ52


subject: UNII:K2J09EMJ52


subject: UNII:K2J09EMJ52


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: Pregnant


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:3723

subject_name: Citalopram


subject: DRUGBANK:DB16533

object_name: respiratory tract infectious disorder


subject: DRUGBANK:DB16533

object_name: Large adenoids


subject: DRUGBANK:DB16533

object_name: Hyperplasia of adenoids


subject: MESH:C000627770

subject_name: folfirinox

object_name: Resectable Pancreatic Ductal Adenocarcinoma


subject: CHEBI:36791

object_name: premature ejaculation


subject: CHEBI:3723


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: ovarian neoplasm


subject: CHEBI:4910

subject_name: Etomidate

object_name: self-limited epilepsy with centrotemporal spikes


subject: CHEBI:5147

subject_name: Formoterol

object_name: Acute asthma


subject: CHEBI:408174

subject_name: Arformoterol


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: stricture


subject: CHEBI:233402

subject_name: zipalertinib

object_name: lung cancer


subject: CHEBI:233402

object_name: lung neoplasm


subject: CHEBI:233402

object_name: lung carcinoma


subject: UMLS:C5239495


subject: UMLS:C5239495


subject: UMLS:C5239495


subject: UNII:T4YMU8TW9H

subject_name: ZIPALERTINIB


subject: UNII:T4YMU8TW9H


subject: UNII:T4YMU8TW9H


subject: CHEMBL.COMPOUND:CHEMBL5314975

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C1614561

subject_name: Polypodium leucotomos

object_name: skin disorder


subject: PUBCHEM.COMPOUND:2781

subject_name: Meclastine

object_name: optic neuritis


subject: CHEBI:3738

subject_name: Clemastine


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: mood (physical finding)


subject: PUBCHEM.COMPOUND:168013087


subject: PUBCHEM.COMPOUND:168013087

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C3274747

subject_name: SR-T100 Gel

object_name: Genital warts


subject: UMLS:C3274747

object_name: vulvar intraepithelial neoplasia


subject: UMLS:C2346810

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:76641559

subject_name: Dorzagliatin

object_name: diabetes mellitus


subject: CHEBI:15365

subject_name: Aspirin

object_name: acute coronary syndrome


subject: CHEBI:31401

subject_name: Cilostazol


subject: CHEBI:84507

subject_name: Chantix

object_name: mental disorder


subject: PUBCHEM.COMPOUND:46783232

subject_name: Champix


subject: UMLS:C1956439


subject: CHEBI:84500

subject_name: varenicline


subject: UMLS:C0935796

subject_name: Annamycin Liposomal

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C0935796

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C0935796

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C0935796

object_name: sarcoma


subject: UMLS:C0935796

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C0935796

object_name: soft tissue sarcoma


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: colorectal carcinoma


subject: UMLS:C4086713

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4086713


subject: UMLS:C4086713

object_name: microsatellite instability high


subject: CHEBI:73629

subject_name: Phe-Asp-Cys

object_name: chronic obstructive pulmonary disease


subject: CHEBI:38848

subject_name: perflunafene


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: UMLS:C5235658

subject_name: Targeted Therapy Agent

object_name: cancer


subject: UMLS:C5235658

object_name: neoplasm


subject: UMLS:C5206567

subject_name: Protein Arginine Methyltransferase 5 Inhibitor PRT543

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UMLS:C5206567

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UMLS:C5206567

object_name: adrenal cortex carcinoma


subject: UMLS:C5206567

object_name: adenoid cystic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594569

subject_name: AMLITELIMAB

object_name: asthma


subject: UMLS:C5555444

subject_name: Amlitelimab


subject: UMLS:C5427906

subject_name: atezolizumab + bevacizumab

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: fibromyalgia


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: breast neoplasm


subject: UMLS:C1521807

object_name: cervical cancer


subject: UMLS:C1521807

object_name: cervical carcinoma


subject: UMLS:C5907918

subject_name: Anti-PD-1/Anti-VEGF Bispecific Antibody JS207


subject: CHEBI:3219

subject_name: Bupropion

object_name: schizoaffective disorder


subject: CHEBI:3219

object_name: schizophrenia 18


subject: UNII:23AEE4Y4ZC

object_name: heart failure


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Metastasis


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Lesion


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Crohn disease


subject: CHEBI:75832

object_name: ulcerative colitis


subject: CHEBI:75832

object_name: inflammatory bowel disease 1


subject: CHEBI:231666


subject: UMLS:C1705207

subject_name: Endostar

object_name: T-Cell Lymphoma


subject: UMLS:C5666916

subject_name: Nebratamig

object_name: Childhood Breast Carcinoma


subject: UMLS:C5666916

object_name: breast carcinoma


subject: UMLS:C5666916

object_name: breast cancer


subject: UMLS:C5854536

subject_name: Anti-HER3/Topoisomerase I Inhibitor Antibody-drug Conjugate DB-1310

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:90943

subject_name: Osimertinib


subject: MESH:C000708971

subject_name: genexol-PM

object_name: non-small cell lung carcinoma


subject: CHEBI:8871

subject_name: Risperidone

object_name: Neuroses, Anxiety


subject: CHEBI:8871

object_name: Anxiety state


subject: UMLS:C3896842

object_name: adult acute myeloid leukemia


subject: UMLS:C3896842

object_name: childhood acute myeloid leukemia


subject: UMLS:C3896842

object_name: acute myeloid leukemia


subject: UMLS:C4085985

subject_name: sabatolimab


subject: UMLS:C4085985


subject: UMLS:C4085985


subject: UNII:A8Y5K4G762

subject_name: TILPISERTIB


subject: UNII:A8Y5K4G762


subject: DRUGBANK:DB18798

subject_name: Tilpisertib


subject: DRUGBANK:DB18798


subject: CHEBI:91512

object_name: prostate carcinoma


subject: CHEBI:91512

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: PUBCHEM.COMPOUND:3628


subject: CHEBI:71019

subject_name: omacetaxine


subject: CHEBI:71019


subject: UMLS:C4719794

subject_name: Atorvastatin Calcium Tablets

object_name: Adverse reaction to COVID-19 vaccine


subject: UMLS:C4719794

object_name: COVID-19 post-intensive care syndrome


subject: UMLS:C4719794

object_name: COVID-19 respiratory infection


subject: UMLS:C4719794

object_name: COVID-19-Associated Thromboembolism


subject: UMLS:C4719794

object_name: COVID-19 stress syndrome


subject: UMLS:C4719794

object_name: COVID-19-Associated Stroke


subject: UNII:DE4G8X55F5

subject_name: Aticaprant

object_name: major depressive disorder


subject: CHEMBL.COMPOUND:CHEMBL2109608

object_name: melanoma


subject: UMLS:C2983744

subject_name: Darleukin


subject: UMLS:C5706445

subject_name: RAS Inhibitor RMC-6236


subject: UMLS:C5706556

subject_name: KRAS G12C Inhibitor RMC-6291


subject: PUBCHEM.COMPOUND:168201327


subject: UMLS:C5907933

subject_name: KRAS G12D Inhibitor RMC-9805


subject: UMLS:C4743011

object_name: EXCESS LMW-DNA


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Renal function disorder


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:71952

subject_name: Dactolisib

object_name: respiratory tract infectious disorder


subject: CHEBI:601027

subject_name: Aliskiren

object_name: chronic kidney disease


subject: CHEBI:601027

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:601027

object_name: proteinuria


subject: CHEBI:601027

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:601027

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:601027

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:149509


subject: CHEBI:149509


subject: CHEBI:149509


subject: CHEBI:149509


subject: CHEBI:149509


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: CHEBI:3347


subject: CHEBI:3347


subject: CHEBI:3347


subject: UMLS:C5237963

subject_name: ADC SKB264

object_name: Carcinoma breast stage IV


subject: CHEBI:64312

subject_name: Memantine

object_name: Attention, concentration or memory problems


subject: CHEBI:64312

object_name: Memory Disorders


subject: CHEBI:74705

subject_name: Met-Leu

object_name: cystic fibrosis


subject: CHEBI:74705

object_name: aspergillosis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole


subject: PUBCHEM.COMPOUND:147912


subject: UNII:21P699C5FC

subject_name: Samatasvir

object_name: chronic hepatitis C virus infection


subject: UMLS:C3502707


subject: UMLS:C0379528

subject_name: gamma-Secretase

object_name: Her2-receptor negative breast cancer


subject: UMLS:C0379528

object_name: Breast cancer recurrent


subject: UMLS:C0379528

object_name: male breast carcinoma


subject: UMLS:C0379528

object_name: triple-negative breast carcinoma


subject: UMLS:C0379528

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C0379528

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C0379528


subject: UMLS:C0379528

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C0379528

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C0379528

object_name: estrogen receptor-negative breast cancer


subject: UMLS:C0379528

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C0379528

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C0379528

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C0379528

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0379528

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0379528

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C0379528

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C0379528

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C0379528

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0379528

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0379528

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:2549

subject_name: Albuterol

object_name: endogenous depression


subject: CHEBI:2549

object_name: major depressive disorder


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Poisoning by, adverse effect of and underdosing of other antidepressants


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEBI:7936

subject_name: Paroxetine


subject: UMLS:C5417945

object_name: Gastroesophageal junction cancer


subject: UMLS:C5417945

object_name: Stomach cancer


subject: UMLS:C5417945

object_name: gastric cancer


subject: UNII:789Q85GA8P

subject_name: Vorasidenib

object_name: Hepatic impairment


subject: DRUGBANK:DB18396

object_name: skin carcinoma


subject: DRUGBANK:DB18396

object_name: trabecular adenocarcinoma


subject: DRUGBANK:DB18396

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: type 2 diabetes mellitus


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: large B-cell lymphoma


subject: UNII:QQA9MLH692

subject_name: Tafasitamab


subject: UMLS:C2987409


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: age-related macular degeneration


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UNII:0VMV8Z3972

object_name: glioma


subject: UNII:0VMV8Z3972

object_name: malignant glioma


subject: UMLS:C5447430

subject_name: Fluorine F 18 DPA-714


subject: UMLS:C5447430


subject: DRUGBANK:DB13975

subject_name: Black cohosh

object_name: Menopause present (finding)


subject: DRUGBANK:DB13975

object_name: Menopause


subject: DRUGBANK:DB13975

object_name: outcomes general quality of life


subject: DRUGBANK:DB13975

object_name: Perceived quality of life


subject: DRUGBANK:DB13975

object_name: Good quality of life


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: severe acute respiratory syndrome


subject: PR:000017019

object_name: respiratory system disorder


subject: PR:000017019

object_name: viral disease


subject: PR:000017019

object_name: respiratory tract infectious disorder


subject: PR:000017019

object_name: RNA Virus Infections


subject: PR:000017019

object_name: Nidovirales infectious disease


subject: PR:000017019

object_name: Coronavinae infectious disease


subject: PR:000017019

object_name: Coronaviridae infectious disease


subject: UMLS:C3272772

object_name: cancer


subject: UMLS:C3272772

object_name: neoplasm


subject: GTOPDB:9757

subject_name: onfekafusp alfa

object_name: Childhood Soft Tissue Sarcoma


subject: GTOPDB:9757

object_name: Adult Soft Tissue Sarcoma


subject: GTOPDB:9757

object_name: sarcoma


subject: GTOPDB:9757

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: GTOPDB:9757

object_name: soft tissue sarcoma


subject: CHEMBL.COMPOUND:CHEMBL4298007

subject_name: ONFEKAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298007


subject: CHEMBL.COMPOUND:CHEMBL4298007


subject: CHEMBL.COMPOUND:CHEMBL4298007


subject: CHEMBL.COMPOUND:CHEMBL4298007


subject: UMLS:C2986395

subject_name: Fibromun


subject: UMLS:C2986395


subject: UMLS:C2986395


subject: UMLS:C2986395


subject: UMLS:C2986395


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: Presenile dementia


subject: UNII:19FUJ2C58T

object_name: dementia


subject: UMLS:C3531686

subject_name: Ginkgo biloba whole extract


subject: UMLS:C3531686


subject: UMLS:C3531686

object_name: Alzheimer disease


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: ST-segment elevation myocardial infarction (STEMI)


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: Ovarian clear cell carcinoma


subject: UNII:P0GVQ9A4S5

object_name: ovarian clear cell cancer


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UNII:0C1JUU9S0L


subject: UNII:0C1JUU9S0L


subject: UMLS:C5441821

subject_name: Farmorubicin

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:47898

subject_name: Epirubicin


subject: UMLS:C2606108

subject_name: ASA 404

object_name: non-small cell lung carcinoma


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: acute respiratory distress syndrome


subject: CHEBI:17650

object_name: acute lung injury


subject: CHEBI:17650

object_name: adult acute respiratory distress syndrome


subject: CHEBI:8378

subject_name: Prednisolone

object_name: pain agnosia


subject: CHEBI:8378

object_name: Pain insensitivity


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:27732


subject: UMLS:C2607549

object_name: atrial fibrillation


subject: UMLS:C2607549

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C2607549

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:20993

subject_name: GLUCOSAMINE

object_name: osteoarthritis


subject: CHEBI:28393

subject_name: D-glucosamine


subject: UNII:63WI9S8P1M

subject_name: Tinlarebant

object_name: severe early-childhood-onset retinal dystrophy


subject: CHEBI:7465

subject_name: Naltrexone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:7465

object_name: obesity


subject: CHEBI:7465

object_name: Obesity, CTCAE


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stomach cancer


subject: CHEBI:231679

object_name: gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: atherosclerosis


subject: MESH:C000712049

subject_name: Monatide (IMS 3015)

object_name: melanoma


subject: CHEBI:167896


subject: CHEBI:10275


subject: PR:000059763

subject_name: apelin receptor early endogenous ligand


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: mucositis


subject: CHEBI:28939

object_name: Transplant-Related Disorder


subject: UMLS:C3827110

object_name: Refractory Hodgkin Lymphoma


subject: UMLS:C3827110

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UMLS:C3827110

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:19J3781LPM

subject_name: Itacitinib


subject: UNII:19J3781LPM


subject: UNII:19J3781LPM


subject: CHEBI:229764

subject_name: Selinexor

object_name: adult acute myeloid leukemia


subject: GTOPDB:13187

subject_name: camoteskimab

object_name: adult-onset Still disease


subject: CHEMBL.COMPOUND:CHEMBL2109604

subject_name: CAMOTESKIMAB


subject: UMLS:C5555534


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Cachexia


subject: PUBCHEM.COMPOUND:3080587

object_name: Anorexia


subject: PUBCHEM.COMPOUND:3080587

object_name: Anorexia, CTCAE


subject: PUBCHEM.COMPOUND:3080587

object_name: Anorexia symptom


subject: PUBCHEM.COMPOUND:3080587

object_name: HIV infection


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen


subject: MESH:C508870

object_name: Klatskin Tumor


subject: CHEBI:80961


subject: CHEBI:80961


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: Prediabetes


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: CHEBI:80165


subject: PUBCHEM.COMPOUND:44216444

subject_name: xenin


subject: UMLS:C0527368

subject_name: xenin 25


subject: CHEBI:57858

subject_name: atropinium


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Childhood Breast Carcinoma


subject: UNII:4EQZ6YO2HI

object_name: breast carcinoma


subject: UNII:4EQZ6YO2HI

object_name: breast cancer


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C0010586

subject_name: Cycloplegics

object_name: cycloplegia


subject: CHEBI:91472

object_name: Childhood Neuroblastoma


subject: CHEBI:91472

object_name: neuroblastoma


subject: CHEBI:7566

subject_name: Nifurtimox


subject: CHEBI:7566


subject: UMLS:C3714145

object_name: schizophrenia


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Bladder cancer stage IV


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UMLS:C0062527

subject_name: Engerix-B

object_name: Cross Infection


subject: PUBCHEM.COMPOUND:2767

object_name: biliary tract neoplasm


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227

object_name: gallbladder neoplasm


subject: CHEBI:90227

object_name: cholangiocarcinoma


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:28364

subject_name: Icosapent


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: CHEMBL.COMPOUND:CHEMBL2108015

subject_name: VITAMIN B COMPLEX


subject: CHEBI:27470

subject_name: Folic acid


subject: UNII:FM5526K07A

subject_name: ZINC ACETATE


subject: UNII:8MSY49469G

subject_name: Fluoromisonidazole F-18

object_name: Recurrent Childhood Glioblastoma


subject: UNII:8MSY49469G

object_name: Recurrent Glioblastoma


subject: MESH:D011819

subject_name: Rabies Vaccines

object_name: Allergy to rabies vaccine


subject: CHEMBL.COMPOUND:CHEMBL2107909

subject_name: RABIES VACCINE


subject: UNII:38RL9AE51Q

subject_name: Anifrolumab

object_name: rheumatoid arthritis


subject: UMLS:C4039583

subject_name: Chimeric antigen receptor

object_name: lymphoid leukemia


subject: PR:000013366

subject_name: proteasome subunit alpha type-7


subject: UMLS:C2986994

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine


subject: UMLS:C4287791

subject_name: c-Met Inhibitor AL2846

object_name: Advanced cancer


subject: CHEBI:3566

subject_name: cetylpyridinium chloride monohydrate

object_name: sarcopenia


subject: CHEBI:32914

subject_name: Cetylpyridinium


subject: CHEBI:165822

subject_name: CpC


subject: PUBCHEM.COMPOUND:54675873


subject: UMLS:C5959582

subject_name: Chromosomal Passenger Complex


subject: UMLS:C5417894

subject_name: Anti-TIM3 Monoclonal Antibody SHR-1702

object_name: acute myeloid leukemia


subject: UMLS:C5417894

object_name: Myelodysplasia


subject: UMLS:C5417894

object_name: Miller-Dieker lissencephaly syndrome


subject: UMLS:C5417894

object_name: myoclonic dystonia 11


subject: UMLS:C5418074

subject_name: ADC MRG002

object_name: Metastatic HER2 positive gastroesophageal junction cancer


subject: CHEBI:94534

subject_name: olanzapine

object_name: bipolar depression


subject: UMLS:C4053648

subject_name: EC-18 cpd


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: De Novo Myelodysplastic Syndrome


subject: UNII:68AYS9A614

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: UNII:68AYS9A614

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UNII:68AYS9A614

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UNII:68AYS9A614

object_name: Previously Treated Myelodysplastic Syndrome


subject: UNII:68AYS9A614

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UNII:68AYS9A614

object_name: Secondary Myelodysplastic Syndrome


subject: UNII:68AYS9A614

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UNII:68AYS9A614

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UNII:68AYS9A614

object_name: recurrent adult acute myeloid leukemia


subject: UNII:68AYS9A614

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: female breast carcinoma


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Safety Issues


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: necrobiosis lipoidica


subject: CHEBI:8776

subject_name: ranitidine

object_name: non-Hodgkin lymphoma


subject: CHEBI:8776

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:8776

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:8776

object_name: acute lymphoblastic leukemia


subject: CHEBI:8776

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Complication of implant


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: UMLS:C5400115

subject_name: Cisplatin Liquid Injection

object_name: oropharyngeal carcinoma


subject: UMLS:C5400115

object_name: oropharynx cancer


subject: UMLS:C4743011

object_name: ulcerative colitis


subject: CHEBI:75929

object_name: Suicidal ideation


subject: CHEBI:75929

object_name: Suicidal Ideation, CTCAE


subject: CHEBI:75929

object_name: mixed anxiety and depressive disorder


subject: CHEBI:75929

object_name: Suicide attempt


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:40009


subject: CHEBI:40009


subject: CHEBI:40009


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:M89N0Q7EQR


subject: CHEBI:134936

subject_name: Pemirolast

object_name: allergic asthma


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan


subject: UNII:FV4Y0JO2CX

subject_name: keyhole-limpet hemocyanin

object_name: liver cirrhosis


subject: UNII:FV4Y0JO2CX

object_name: hepatitis C


subject: UNII:FV4Y0JO2CX

object_name: chronic hepatitis C virus infection


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Blood Loss


subject: CHEBI:63610

object_name: Hemorrhage


subject: MESH:D056692

subject_name: Prebiotics

object_name: Drug Resistant Epilepsy


subject: PUBCHEM.COMPOUND:19609831

subject_name: Rebimastat

object_name: malignant soft tissue neoplasm


subject: PUBCHEM.COMPOUND:19609831

object_name: sarcoma


subject: CHEBI:3757

subject_name: Clonidine

object_name: Closed Fracture


subject: CHEBI:3757

object_name: Knee arthropathy


subject: CHEBI:3757

object_name: Coxitis


subject: UMLS:C0360032

subject_name: EMLA Cream


subject: UMLS:C0360032


subject: UMLS:C0360032


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:8024

subject_name: Perindopril

object_name: essential hypertension


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Stage II Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage IV Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage IB Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage IIA Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage IIB Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Stage III Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage IVB Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage IVA Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage IIIB Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Ann Arbor Stage IIIA Hodgkin Lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:8499

subject_name: Propranolol

object_name: Misophonia


subject: CHEBI:27732

subject_name: Caffeine

object_name: atopic eczema


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: Peripartum cardiomyopathy, postpartum condition or complication


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: RXCUI:901639

subject_name: Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe

object_name: Recurrent lower respiratory tract infections


subject: RXCUI:901639

object_name: Upper Respiratory Infections


subject: RXCUI:901639

object_name: Disorder characterized by fever


subject: RXCUI:901639

object_name: otitis media


subject: RXCUI:901639

object_name: infectious otitis media


subject: RXCUI:901639

object_name: Otitis Media, CTCAE


subject: RXCUI:901639

object_name: Cough


subject: RXCUI:901639

object_name: Cough, CTCAE


subject: UMLS:C3252923

subject_name: synflorix


subject: UMLS:C3252923


subject: UMLS:C3252923


subject: UMLS:C3252923


subject: UMLS:C3252923


subject: UMLS:C3252923


subject: UMLS:C3252923


subject: UMLS:C3252923


subject: CHEBI:132922

object_name: Surgical procedure finding


subject: CHEBI:132922

object_name: Lower extremity problem


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UMLS:C1443167

subject_name: Bougainvillea antigen

object_name: diabetes mellitus


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: chronic kidney disease


subject: CHEBI:64816

object_name: Refractory Nasopharyngeal Carcinoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:5864

subject_name: Ifosfamide


subject: UNII:7NL2E3F6K3

subject_name: Emicizumab

object_name: acquired hemophilia A


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: thrombocytopenia


subject: UMLS:C2984518

subject_name: tabalumab

object_name: rheumatoid arthritis


subject: CHEBI:16796

subject_name: Melatonin

object_name: Coronary artery calcification


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Cerebral Vasospasm


subject: CHEBI:70752

subject_name: Dabigatran

object_name: Thromboembolism


subject: CHEBI:88249

subject_name: Mirdametinib

object_name: childhood low-grade glioma


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: maturity-onset diabetes of the young type 1


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:78140854

object_name: IDH gene mutation


subject: CHEMBL.COMPOUND:CHEMBL4297814

subject_name: ZINPENTRAXIN ALFA

object_name: interstitial lung disease 1


subject: CHEMBL.COMPOUND:CHEMBL4297814

object_name: interstitial lung disease 2


subject: CHEBI:135515

subject_name: Bendamustine

object_name: cancer


subject: CHEBI:28887

subject_name: Ofatumumab


subject: CHEBI:28887

object_name: neoplasm


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: CHEBI:63626

subject_name: Tesamorelin

object_name: lipodystrophy


subject: UMLS:C1313807


subject: UNII:HOU4I0G29C

subject_name: Netazepide

object_name: chronic atrophic gastritis


subject: UNII:HOU4I0G29C

object_name: Hypergastrinemia (finding)


subject: UNII:HOU4I0G29C

object_name: Hypergastrinemia


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: Crohn disease


subject: UMLS:C0665297

subject_name: natalizumab


subject: CHEBI:16118

subject_name: Berberine

object_name: Heart Disease Risk Factors


subject: MESH:C000712049

subject_name: Monatide (IMS 3015)

object_name: central nervous system cancer


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: paranasal sinus squamous cell carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:231614

subject_name: Nivolumab

object_name: laryngeal squamous cell carcinoma


subject: CHEBI:231614

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:231614

object_name: oropharynx squamous cell carcinoma


subject: CHEBI:231614


subject: CHEBI:231614

object_name: hypopharynx squamous cell carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:38940

subject_name: Sunitinib

object_name: colorectal neoplasm


subject: UNII:L1F3R18W77

subject_name: Asciminib

object_name: kidney failure


subject: CHEBI:221840

object_name: childhood neoplasm


subject: CHEBI:221840

object_name: neoplastic syndrome


subject: CHEBI:221840

object_name: cancer or benign tumor


subject: CHEBI:221840

object_name: neoplasm


subject: CHEBI:221840

object_name: prostate cancer


subject: CHEBI:221840

object_name: prostate neoplasm


subject: CHEBI:221840

object_name: Childhood Breast Carcinoma


subject: CHEBI:221840

object_name: breast carcinoma


subject: CHEBI:221840

object_name: breast cancer


subject: CHEBI:221840

object_name: adult lymphoma


subject: CHEBI:221840

object_name: lymphoma


subject: CHEBI:221840

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: CHEBI:221846


subject: CHEBI:221846


subject: CHEBI:221846


subject: CHEBI:221846


subject: CHEBI:221846


subject: CHEBI:221846


subject: CHEBI:221846


subject: CHEBI:221846


subject: CHEBI:221846


subject: CHEBI:221846


subject: CHEBI:221846


subject: CHEBI:221846


subject: UMLS:C0950721

subject_name: UCN 01


subject: UMLS:C0950721


subject: UMLS:C0950721


subject: UMLS:C0950721


subject: UMLS:C0950721


subject: UMLS:C0950721


subject: UMLS:C0950721


subject: UMLS:C0950721


subject: UMLS:C0950721


subject: UMLS:C0950721


subject: UMLS:C0950721


subject: UMLS:C0950721


subject: CHEBI:151315

subject_name: Heparin

object_name: intracerebral hemorrhage


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:59204

subject_name: Carbetocin

object_name: Sensory Loss


subject: CHEBI:59204

object_name: pregnancy related


subject: CHEBI:131174

subject_name: Navitoclax

object_name: Childhood Solid Neoplasm


subject: CHEBI:131174

object_name: Adult Solid Neoplasm


subject: CHEBI:131174

object_name: Solid Neoplasm


subject: UMLS:C1831992

subject_name: ABT 263


subject: UMLS:C1831992


subject: UMLS:C1831992


subject: CHEBI:8988

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C2346820


subject: UMLS:C4725689

subject_name: EP4 Antagonist ONO-4578


subject: CHEBI:28061

subject_name: galactose

object_name: liver cancer


subject: CHEBI:28061

object_name: liver carcinoma


subject: CHEBI:42905

subject_name: L-Galactose


subject: CHEBI:42905


subject: KEGG.COMPOUND:C01582

subject_name: Galactose


subject: KEGG.COMPOUND:C01582


subject: CHEBI:231324

subject_name: alpelisib

object_name: rectal carcinoma


subject: CHEBI:231324

object_name: rectal cancer


subject: CHEBI:231324

object_name: Childhood Rectal Carcinoma


subject: UMLS:C2986399


subject: UMLS:C2986399


subject: UMLS:C2986399


subject: UMLS:C5815513

subject_name: Japanese Encephalitis Vaccine, Inactivated, Adsorbed

object_name: viral disease


subject: UMLS:C5815513

object_name: infectious disease


subject: UMLS:C5815513

object_name: Japanese encephalitis


subject: UMLS:C5815513

object_name: yellow fever


subject: UMLS:C2682870

subject_name: Ixiaro


subject: UMLS:C2682870


subject: UMLS:C2682870


subject: UMLS:C2682870


subject: UMLS:C4325296

subject_name: Stamaril


subject: UMLS:C4325296


subject: UMLS:C4325296


subject: UMLS:C4325296


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: herpes zoster


subject: CHEBI:41879

object_name: postherpetic neuralgia


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: periodontitis


subject: CHEBI:22652

object_name: diabetes mellitus type 2 with hyperglycemia


subject: UMLS:C2703114

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:137229597

subject_name: Inosine pranobex

object_name: lymphoid system disorder


subject: PUBCHEM.COMPOUND:137229597

object_name: Lymphadenopathy


subject: PUBCHEM.COMPOUND:137229597

object_name: HIV infection


subject: UNII:W1SO0V223F

subject_name: Delimmun


subject: UNII:W1SO0V223F


subject: UNII:W1SO0V223F


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: kidney failure


subject: CHEBI:28939

object_name: Renal Failure, CTCAE


subject: CHEBI:60802

subject_name: ropivacaine

object_name: hip pain chronic


subject: CHEBI:60802

object_name: chronic hip pain


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: asthma


subject: UMLS:C4763757

subject_name: Erfonrilimab

object_name: digestive system cancer


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:59527

object_name: Pleural effusion


subject: CHEBI:59527

object_name: Pleural Effusion, CTCAE


subject: CHEBI:59527

object_name: x-ray of chest: pleural effusion


subject: CHEBI:59527

object_name: Malignant pleural effusion


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:91939


subject: CHEBI:91939


subject: CHEBI:91939


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: UMLS:C2958914

subject_name: INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT

object_name: Drooling


subject: DRUGBANK:DB06184

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Advanced Soft Tissue Sarcoma


subject: CHEBI:231679

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:231679

object_name: Metastatic Soft Tissue Sarcoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:135515

subject_name: Bendamustine

object_name: EXCESS LMW-DNA


subject: UMLS:C5444129

subject_name: Latent Membrane Protein 2

object_name: nasopharyngeal neoplasm


subject: CHEBI:95165

object_name: Mesothelioma


subject: CHEBI:95165

object_name: mesothelial neoplasm


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW

object_name: malignant mesothelioma


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:9150

object_name: malignant neoplasm of breast stage I


subject: CHEBI:9150

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:9150

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:9150

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:9150

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:9150

object_name: invasive breast carcinoma


subject: UMLS:C4744992

subject_name: Factor B Inhibitor LNP023


subject: CHEBI:229652

subject_name: Iptacopan


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: primary central nervous system lymphoma


subject: UMLS:C0733521

subject_name: Ara-C


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:3423

subject_name: Carmustine


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Acute gastroenteritis


subject: CHEBI:7773

object_name: gastroenteritis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: pharyngitis


subject: CHEBI:4466

object_name: Pharyngalgia


subject: CHEBI:4466

object_name: Sore Throat, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: esophageal squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: PUBCHEM.COMPOUND:14907381

object_name: vitiligo


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: UNII:B058ME29VU

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:B058ME29VU

object_name: Stage IVB Pancreatic Cancer


subject: UNII:B058ME29VU

object_name: Pancreatic carcinoma stage IVA


subject: UNII:B058ME29VU

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:B058ME29VU

object_name: Pancreatic carcinoma stage III


subject: UNII:B058ME29VU

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:B058ME29VU

object_name: pancreatic adenocarcinoma


subject: UNII:B058ME29VU

object_name: Stage IV Ampulla of Vater Cancer AJCC v7


subject: UNII:B058ME29VU

object_name: Stage IV Ampulla of Vater Cancer AJCC v8


subject: UNII:B058ME29VU

object_name: Stage III Ampulla of Vater Cancer AJCC v8


subject: UNII:B058ME29VU

object_name: Stage III Ampulla of Vater Cancer AJCC v7


subject: UNII:B058ME29VU

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: UNII:B058ME29VU

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: UNII:B058ME29VU

object_name: stage IVA gallbladder cancer


subject: UNII:B058ME29VU

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: UNII:B058ME29VU

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: UNII:B058ME29VU

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: UNII:B058ME29VU

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: UNII:B058ME29VU

object_name: stage IIIA gallbladder cancer


subject: UNII:B058ME29VU

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: UNII:B058ME29VU

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: UNII:B058ME29VU

object_name: Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7


subject: UNII:B058ME29VU

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v7


subject: UNII:B058ME29VU

object_name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7


subject: UNII:B058ME29VU

object_name: Stage IIIB Hilar Cholangiocarcinoma AJCC v7


subject: UNII:B058ME29VU

object_name: Stage IIIB Hilar Cholangiocarcinoma AJCC v8


subject: UNII:B058ME29VU

object_name: Stage IIIA Hilar Cholangiocarcinoma AJCC v8


subject: UNII:B058ME29VU

object_name: Stage IIIA Hilar Cholangiocarcinoma AJCC v7


subject: UNII:B058ME29VU

object_name: Stage IVA Hilar Cholangiocarcinoma AJCC v7


subject: UNII:B058ME29VU

object_name: Stage IVA Hilar Cholangiocarcinoma AJCC v8


subject: UNII:B058ME29VU

object_name: Stage IVB Hilar Cholangiocarcinoma AJCC v8


subject: UNII:B058ME29VU

object_name: Stage IVB Hilar Cholangiocarcinoma AJCC v7


subject: UNII:B058ME29VU

object_name: ampulla of vater adenocarcinoma


subject: UNII:B058ME29VU

object_name: gallbladder adenocarcinoma


subject: PR:000004555

subject_name: alcohol dehydrogenase 1

object_name: Pancreatic adenocarcinoma metastatic


subject: PR:000004555

object_name: Stage IVB Pancreatic Cancer


subject: PR:000004555

object_name: Pancreatic carcinoma stage IVA


subject: PR:000004555

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PR:000004555

object_name: Pancreatic carcinoma stage III


subject: PR:000004555

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: PR:000004555

object_name: pancreatic adenocarcinoma


subject: PR:000004555

object_name: Stage IV Ampulla of Vater Cancer AJCC v7


subject: PR:000004555

object_name: Stage IV Ampulla of Vater Cancer AJCC v8


subject: PR:000004555

object_name: Stage III Ampulla of Vater Cancer AJCC v8


subject: PR:000004555

object_name: Stage III Ampulla of Vater Cancer AJCC v7


subject: PR:000004555

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: PR:000004555

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: PR:000004555

object_name: stage IVA gallbladder cancer


subject: PR:000004555

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: PR:000004555

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: PR:000004555

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: PR:000004555

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: PR:000004555

object_name: stage IIIA gallbladder cancer


subject: PR:000004555

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: PR:000004555

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: PR:000004555

object_name: Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7


subject: PR:000004555

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v7


subject: PR:000004555

object_name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7


subject: PR:000004555

object_name: Stage IIIB Hilar Cholangiocarcinoma AJCC v7


subject: PR:000004555

object_name: Stage IIIB Hilar Cholangiocarcinoma AJCC v8


subject: PR:000004555

object_name: Stage IIIA Hilar Cholangiocarcinoma AJCC v8


subject: PR:000004555

object_name: Stage IIIA Hilar Cholangiocarcinoma AJCC v7


subject: PR:000004555

object_name: Stage IVA Hilar Cholangiocarcinoma AJCC v7


subject: PR:000004555

object_name: Stage IVA Hilar Cholangiocarcinoma AJCC v8


subject: PR:000004555

object_name: Stage IVB Hilar Cholangiocarcinoma AJCC v8


subject: PR:000004555

object_name: Stage IVB Hilar Cholangiocarcinoma AJCC v7


subject: PR:000004555

object_name: ampulla of vater adenocarcinoma


subject: PR:000004555

object_name: gallbladder adenocarcinoma


subject: UMLS:C1706643

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C1706643

object_name: Stage IVB Pancreatic Cancer


subject: UMLS:C1706643

object_name: Pancreatic carcinoma stage IVA


subject: UMLS:C1706643

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C1706643

object_name: Pancreatic carcinoma stage III


subject: UMLS:C1706643

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1706643

object_name: pancreatic adenocarcinoma


subject: UMLS:C1706643

object_name: Stage IV Ampulla of Vater Cancer AJCC v7


subject: UMLS:C1706643

object_name: Stage IV Ampulla of Vater Cancer AJCC v8


subject: UMLS:C1706643

object_name: Stage III Ampulla of Vater Cancer AJCC v8


subject: UMLS:C1706643

object_name: Stage III Ampulla of Vater Cancer AJCC v7


subject: UMLS:C1706643

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: UMLS:C1706643

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: UMLS:C1706643

object_name: stage IVA gallbladder cancer


subject: UMLS:C1706643

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: UMLS:C1706643

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: UMLS:C1706643

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: UMLS:C1706643

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: UMLS:C1706643

object_name: stage IIIA gallbladder cancer


subject: UMLS:C1706643

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: UMLS:C1706643

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: UMLS:C1706643

object_name: Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7


subject: UMLS:C1706643

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v7


subject: UMLS:C1706643

object_name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7


subject: UMLS:C1706643

object_name: Stage IIIB Hilar Cholangiocarcinoma AJCC v7


subject: UMLS:C1706643

object_name: Stage IIIB Hilar Cholangiocarcinoma AJCC v8


subject: UMLS:C1706643

object_name: Stage IIIA Hilar Cholangiocarcinoma AJCC v8


subject: UMLS:C1706643

object_name: Stage IIIA Hilar Cholangiocarcinoma AJCC v7


subject: UMLS:C1706643

object_name: Stage IVA Hilar Cholangiocarcinoma AJCC v7


subject: UMLS:C1706643

object_name: Stage IVA Hilar Cholangiocarcinoma AJCC v8


subject: UMLS:C1706643

object_name: Stage IVB Hilar Cholangiocarcinoma AJCC v8


subject: UMLS:C1706643

object_name: Stage IVB Hilar Cholangiocarcinoma AJCC v7


subject: UMLS:C1706643

object_name: ampulla of vater adenocarcinoma


subject: UMLS:C1706643

object_name: gallbladder adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Pancreatic Cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Pancreatic carcinoma stage IVA


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Pancreatic carcinoma stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: pancreatic adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Ampulla of Vater Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Ampulla of Vater Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Ampulla of Vater Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Ampulla of Vater Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IVA gallbladder cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: stage IIIA gallbladder cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: ampulla of vater adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: gallbladder adenocarcinoma


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Stage IVB Pancreatic Cancer


subject: CHEBI:175901

object_name: Stage IV Ampulla of Vater Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage IV Ampulla of Vater Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage III Ampulla of Vater Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage III Ampulla of Vater Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: CHEBI:175901

object_name: stage IVA gallbladder cancer


subject: CHEBI:175901

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: CHEBI:175901

object_name: stage IIIA gallbladder cancer


subject: CHEBI:175901

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: CHEBI:175901

object_name: ampulla of vater adenocarcinoma


subject: CHEBI:175901

object_name: gallbladder adenocarcinoma


subject: UMLS:C2604584

object_name: osteoarthritis, knee


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: Metastatic thymic carcinoma


subject: UNII:D99YVK4L0X

object_name: Locally Advanced Thymus Carcinoma


subject: UNII:D99YVK4L0X

object_name: Unresectable Thymus Carcinoma


subject: UNII:D99YVK4L0X

object_name: Recurrent Thymus Carcinoma


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: squamous cell carcinoma


subject: CHEBI:38545

object_name: non-small cell lung carcinoma


subject: CHEBI:50848

subject_name: Loteprednol

object_name: Inflammatory abnormality of the eye


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: lung cancer


subject: UNII:B72HH48FLU

object_name: lung neoplasm


subject: UNII:B72HH48FLU

object_name: lung carcinoma


subject: UNII:B72HH48FLU

object_name: Anorexia


subject: UNII:B72HH48FLU

object_name: Anorexia, CTCAE


subject: UNII:B72HH48FLU

object_name: Anorexia symptom


subject: UNII:B72HH48FLU

object_name: Cachexia


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: age


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Acute Kidney Insufficiency


subject: PUBCHEM.COMPOUND:54675783

object_name: acute kidney failure


subject: CHEBI:145373

subject_name: Pexidartinib

object_name: tenosynovial giant cell tumor


subject: CHEBI:145373

object_name: tenosynovial giant cell tumor, diffuse type


subject: CHEBI:80270

object_name: coronary stenosis


subject: CHEBI:80270

object_name: Angina pectoris


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: PR:000008039


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C0061355


subject: CHEBI:29337

subject_name: azanide


subject: CHEBI:29337


subject: CHEBI:37622

subject_name: carboxamide


subject: CHEBI:37622


subject: CHEBI:32988

subject_name: amide


subject: CHEBI:32988


subject: MESH:C000627770

subject_name: folfirinox

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: MESH:C000627770

object_name: stage IV pancreatic cancer


subject: MESH:C000627770

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801


subject: CHEBI:6801


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Crow's feet


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: CHEBI:7824

subject_name: Oxcarbazepine

object_name: multiple sclerosis


subject: DRUGBANK:DB05918

object_name: neurofibroma


subject: UMLS:C3838813

subject_name: BRAF inhibitor (product)

object_name: cancer


subject: UMLS:C3838813

object_name: neoplasm


subject: CHEBI:139072

object_name: anxiety


subject: CHEBI:139072

object_name: anxiety disorder


subject: CHEBI:139072

object_name: Anxiety symptoms


subject: CHEBI:139072

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:139072

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:139072

object_name: Osteochondritis


subject: CHEBI:139072


subject: CHEBI:139072

object_name: Alcohol or Other Drugs use


subject: CHEBI:139072

object_name: substance use (history)


subject: CHEBI:139072

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:39548

object_name: metabolic syndrome X


subject: CHEBI:63660


subject: CHEBI:63660


subject: CHEBI:63660

object_name: diabetes mellitus


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: CHEBI:63618


subject: UNII:2AW48LAZ4I

subject_name: IMETELSTAT SODIUM

object_name: glioma susceptibility 1


subject: UNII:2AW48LAZ4I

object_name: ependymoma


subject: UNII:2AW48LAZ4I

object_name: childhood ependymoma


subject: UNII:2AW48LAZ4I

object_name: Newly Diagnosed Childhood Ependymoma


subject: UNII:2AW48LAZ4I

object_name: Adult Ependymoma


subject: UNII:2AW48LAZ4I

object_name: anaplastic ependymoma


subject: UNII:2AW48LAZ4I

object_name: adult anaplastic ependymoma


subject: UNII:2AW48LAZ4I

object_name: Childhood Anaplastic Ependymoma


subject: UNII:2AW48LAZ4I

object_name: brainstem neoplasm


subject: UNII:2AW48LAZ4I

object_name: Adult Giant Cell Glioblastoma


subject: UNII:2AW48LAZ4I

object_name: Childhood Giant Cell Glioblastoma


subject: UNII:2AW48LAZ4I

object_name: giant cell glioblastoma


subject: UNII:2AW48LAZ4I

object_name: diffuse astrocytoma


subject: UNII:2AW48LAZ4I

object_name: adult oligodendroglioma


subject: UNII:2AW48LAZ4I

object_name: oligodendroglioma


subject: UNII:2AW48LAZ4I

object_name: childhood oligodendroglioma


subject: UNII:2AW48LAZ4I

object_name: Grade III Childhood Astrocytoma


subject: UNII:2AW48LAZ4I

object_name: Adult Anaplastic Astrocytoma


subject: UNII:2AW48LAZ4I

object_name: anaplastic astrocytoma


subject: UNII:2AW48LAZ4I

object_name: glioblastoma


subject: UNII:2AW48LAZ4I

object_name: Childhood Glioblastoma


subject: UNII:2AW48LAZ4I

object_name: adult glioblastoma


subject: UNII:2AW48LAZ4I

object_name: Adult Gliosarcoma


subject: UNII:2AW48LAZ4I

object_name: gliosarcoma


subject: UNII:2AW48LAZ4I

object_name: Childhood Gliosarcoma


subject: UNII:F60NE4XB53

subject_name: imetelstat

object_name: glioma susceptibility 1


subject: UNII:F60NE4XB53

object_name: ependymoma


subject: UNII:F60NE4XB53

object_name: childhood ependymoma


subject: UNII:F60NE4XB53

object_name: Newly Diagnosed Childhood Ependymoma


subject: UNII:F60NE4XB53

object_name: Adult Ependymoma


subject: UNII:F60NE4XB53

object_name: anaplastic ependymoma


subject: UNII:F60NE4XB53

object_name: adult anaplastic ependymoma


subject: UNII:F60NE4XB53

object_name: Childhood Anaplastic Ependymoma


subject: UNII:F60NE4XB53

object_name: brainstem neoplasm


subject: UNII:F60NE4XB53

object_name: Adult Giant Cell Glioblastoma


subject: UNII:F60NE4XB53

object_name: Childhood Giant Cell Glioblastoma


subject: UNII:F60NE4XB53

object_name: giant cell glioblastoma


subject: UNII:F60NE4XB53

object_name: diffuse astrocytoma


subject: UNII:F60NE4XB53

object_name: adult oligodendroglioma


subject: UNII:F60NE4XB53

object_name: oligodendroglioma


subject: UNII:F60NE4XB53

object_name: childhood oligodendroglioma


subject: UNII:F60NE4XB53

object_name: Grade III Childhood Astrocytoma


subject: UNII:F60NE4XB53

object_name: Adult Anaplastic Astrocytoma


subject: UNII:F60NE4XB53

object_name: anaplastic astrocytoma


subject: UNII:F60NE4XB53

object_name: glioblastoma


subject: UNII:F60NE4XB53

object_name: Childhood Glioblastoma


subject: UNII:F60NE4XB53

object_name: adult glioblastoma


subject: UNII:F60NE4XB53

object_name: Adult Gliosarcoma


subject: UNII:F60NE4XB53

object_name: gliosarcoma


subject: UNII:F60NE4XB53

object_name: Childhood Gliosarcoma


subject: UMLS:C5907908

subject_name: ALK Inhibitor SY-3505

object_name: non-small cell lung carcinoma


subject: UNII:82M942WZ4A

object_name: retinal detachment


subject: UNII:82M942WZ4A

object_name: Retinal Detachment, CTCAE 3.0


subject: UNII:82M942WZ4A

object_name: Retinal Detachment, CTCAE 5.0


subject: UMLS:C1143399


subject: UMLS:C1143399


subject: UMLS:C1143399


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:71219

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: CHEBI:93786


subject: UMLS:C1318898

subject_name: 5-alpha Reductase Inhibitor [EPC]

object_name: benign prostatic hyperplasia


subject: UMLS:C2936788

subject_name: 5-alpha Reductase Inhibitors


subject: UMLS:C5446896

subject_name: PI3K-delta Inhibitor BGB-10188

object_name: mantle cell lymphoma


subject: UMLS:C5446896

object_name: follicular lymphoma


subject: UMLS:C5446896

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5446896

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5446896

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5446896

object_name: marginal zone lymphoma


subject: UMLS:C5446896

object_name: MALT lymphoma


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: adult lymphoma


subject: UNII:7XL5ISS668

object_name: lymphoma


subject: UNII:7XL5ISS668

object_name: pediatric lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:31355

subject_name: Carboplatin

object_name: non-Hodgkin lymphoma


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:18258

subject_name: Liothyronine

object_name: endogenous depression


subject: CHEBI:18258

object_name: major depressive disorder


subject: UMLS:C0010826

subject_name: Cytomel


subject: UMLS:C0010826


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: female reproductive organ cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: desmoplastic melanoma


subject: UNII:DPT0O3T46P

object_name: spindle cell melanoma


subject: PUBCHEM.COMPOUND:2269

object_name: diarrhea


subject: PUBCHEM.COMPOUND:2269

object_name: rectal discharge diarrhea (physical finding)


subject: PUBCHEM.COMPOUND:2269

object_name: Diarrhea, CTCAE


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: lung adenocarcinoma


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: asthma


subject: UMLS:C1963001

subject_name: Cheese cottage (antigen)

object_name: Nutritional status


subject: UMLS:C2984024

subject_name: Ferric Carboxymaltose Solution

object_name: Anemia, CTCAE


subject: CHEBI:28915

subject_name: Fosfomycin

object_name: anemia


subject: CHEBI:28915


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: Refractory Grade 3a Follicular Lymphoma


subject: UNII:LDJ89SS0YG

object_name: Refractory Grade 2 Follicular Lymphoma


subject: UNII:LDJ89SS0YG

object_name: Refractory Grade 1 Follicular Lymphoma


subject: UNII:LDJ89SS0YG

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: UNII:LDJ89SS0YG

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:LDJ89SS0YG

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UNII:Y333RS1786

subject_name: Cenerimod

object_name: EXCESS LMW-DNA


subject: UNII:Y333RS1786

object_name: lupus nephritis


subject: CHEBI:196955

subject_name: Atogepant

object_name: Transformed migraine


subject: CHEBI:196955

object_name: migraine


subject: CHEBI:196955

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:38545

object_name: kidney failure


subject: CHEBI:38545

object_name: Renal Failure, CTCAE


subject: MESH:D056692

subject_name: Prebiotics

object_name: Bowel Function


subject: UNII:4521NR0J09

object_name: psoriasis


subject: UNII:6897GXD6OE

object_name: idiopathic scoliosis


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: undifferentiated embryonal sarcoma of the liver


subject: UNII:DPT0O3T46P

object_name: undifferentiated sarcoma of soft tissue


subject: UNII:DPT0O3T46P

object_name: undifferentiated (embryonal) sarcoma


subject: UNII:DPT0O3T46P

object_name: Anaplastic sarcoma


subject: UNII:DPT0O3T46P

object_name: HER2 protein overexpression


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Childhood Synovial Sarcoma


subject: CHEBI:231614

object_name: Adult Synovial Sarcoma


subject: CHEBI:231614

object_name: synovial sarcoma


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:231614

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:231614

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:231614

object_name: soft tissue sarcoma


subject: CHEBI:231614


subject: CHEBI:4702

subject_name: Dorzolamide

object_name: drugs; glaucoma


subject: CHEBI:60787

subject_name: TIMOLOL

object_name: open-angle glaucoma


subject: CHEBI:60787


subject: CHEBI:39465

subject_name: timolol


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: head and neck cancer


subject: UMLS:C5206660

subject_name: Anbenitamab

object_name: Childhood Breast Carcinoma


subject: UMLS:C5206660

object_name: breast carcinoma


subject: UMLS:C5206660

object_name: breast cancer


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: chronic kidney disease


subject: CHEBI:81579

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:7FY24HE2G3

subject_name: Tanakan

object_name: malaria


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:39548

object_name: impotence


subject: CHEBI:39548

object_name: prostate adenocarcinoma


subject: CHEBI:39548

object_name: Unable to perform sex


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: CHEBI:7986


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:125427

object_name: cocaine use disorder


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: RXCUI:1040052

subject_name: dextromethorphan / quinidine Oral Capsule

object_name: traumatic encephalopathy


subject: RXCUI:1040052

object_name: Presenile dementia


subject: RXCUI:1040052

object_name: dementia


subject: RXCUI:1040052

object_name: stroke disorder


subject: RXCUI:1040052

object_name: cerebrovascular disorder


subject: RXCUI:1040052

object_name: Stroke (heart beat)


subject: RXCUI:1040052

object_name: Stroke, CTCAE


subject: CHEBI:10127

subject_name: Zonisamide

object_name: Weight Gain


subject: CHEBI:10127

object_name: Weight Gain, CTCAE


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:94534


subject: MESH:C507879

subject_name: cytoflavin

object_name: Ischemic stroke


subject: MESH:C507879

object_name: Acute Stroke


subject: CHEBI:64019

subject_name: Nebivolol


subject: CHEBI:31932

subject_name: olmesartan


subject: UNII:61XQN688TW

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:11614352


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:54726193

object_name: pneumonia


subject: PUBCHEM.COMPOUND:54726193

object_name: COVID-19-Associated Pneumonia


subject: UNII:Y6IUM7395Q


subject: UNII:Y6IUM7395Q


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Metastatic urothelial carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Cognitive changes


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:BTY153760O

subject_name: Ixekizumab

object_name: psoriasis-related juvenile idiopathic arthritis


subject: UNII:BTY153760O

object_name: enthesitis-related juvenile idiopathic arthritis


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Vomiting, Postoperative


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17634

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: post-traumatic stress disorder


subject: CHEBI:125535

subject_name: Esreboxetine


subject: CHEBI:135342

subject_name: Reboxetine


subject: UNII:1D2T74921W

subject_name: NAFAMOSTAT MESYLATE

object_name: ANTICOAGULATION (finding)


subject: UNII:1D2T74921W

object_name: Critical Illness


subject: PUBCHEM.COMPOUND:9868041


subject: PUBCHEM.COMPOUND:9868041


subject: CHEBI:135466

subject_name: Nafamostat


subject: CHEBI:135466


subject: UMLS:C0207682

subject_name: nafamostat mesilate


subject: UMLS:C0207682


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: methicillin-resistant staphylococcus aureus infectious disease


subject: CHEBI:16480

object_name: Skin ulcer


subject: CHEBI:63631

subject_name: Topiramate

object_name: Chronic Headache


subject: CHEBI:63631

object_name: headache disorder


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: colorectal adenocarcinoma


subject: UMLS:C4329339

object_name: Solid Neoplasm


subject: CHEBI:28838

subject_name: Lutein

object_name: macular degeneration


subject: CHEBI:28838

object_name: retinitis pigmentosa 30


subject: CHEBI:64816

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Metastatic malignant neoplasm to liver


subject: PUBCHEM.COMPOUND:70789204

object_name: PPoma


subject: PUBCHEM.COMPOUND:70789204

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: pancreatic somatostatinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: somatostatinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: recurrent islet cell carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: glucagonoma


subject: PUBCHEM.COMPOUND:70789204

object_name: insulinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Zollinger-Ellison syndrome


subject: PUBCHEM.COMPOUND:70789204

object_name: gastrinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: pancreatic gastrinoma


subject: CHEBI:8364

subject_name: Prazosin

object_name: Alzheimer disease


subject: CHEBI:49005

subject_name: Deferasirox

object_name: hemochromatosis


subject: CHEBI:49005

object_name: hemosiderosis


subject: CHEBI:94793

subject_name: Pimasertib

object_name: Solid Neoplasm


subject: CHEBI:94793

object_name: neoplasm


subject: UMLS:C3642441


subject: UMLS:C3642441

object_name: cancer


subject: UMLS:C3642441


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: triple-negative breast carcinoma


subject: CHEBI:17925

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: prostate carcinoma


subject: UNII:1C6V77QF41

object_name: prostate cancer


subject: UMLS:C2981820

object_name: melanoma


subject: CHEBI:145373

subject_name: Pexidartinib


subject: CHEBI:81862

object_name: Sprains and Strains


subject: CHEBI:81862

object_name: metabolic bone disorder


subject: CHEBI:81862

object_name: Weight Change


subject: CHEBI:81862

object_name: cardiovascular disorder


subject: CHEBI:81862

object_name: Abnormality of acid-base homeostasis


subject: UMLS:C3273107

subject_name: Elinogrel Potassium

object_name: myocardial infarction


subject: UMLS:C3273107

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C3273107

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:68584

subject_name: Ezogabine

object_name: Depressed mood


subject: CHEBI:68584

object_name: Anhedonia


subject: UMLS:C0002007

subject_name: Aldosterone Antagonists

object_name: heart failure


subject: UMLS:C0002007

object_name: Heart Failure, CTCAE


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin

object_name: adult lymphoma


subject: UNII:KG6VO684Z6

object_name: lymphoma


subject: UNII:KG6VO684Z6

object_name: pediatric lymphoma


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C0302908

subject_name: Liquid substance


subject: UMLS:C0302908


subject: UMLS:C0302908


subject: UNII:E8R04MBQ04


subject: UNII:E8R04MBQ04


subject: UNII:E8R04MBQ04


subject: UNII:E8R04MBQ04

object_name: neoplasm


subject: UMLS:C2830202


subject: UMLS:C2830202


subject: UMLS:C2830202


subject: UMLS:C2830202


subject: CHEBI:90942

subject_name: Ixazomib


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:7496

subject_name: Nelfinavir


subject: CHEBI:7496


subject: CHEBI:7496


subject: CHEBI:7496


subject: UniProtKB:Q9USH8

subject_name: GLU2B_SCHPO Glucosidase 2 subunit beta (sprot)

object_name: Irritable bowel syndrome with diarrhea


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Indolent Non-Hodgkin Lymphoma


subject: CHEBI:135515

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: schwannomatosis


subject: UNII:I5I8VB78VT

object_name: schwannoma


subject: UNII:I5I8VB78VT

object_name: Chronic pain


subject: UMLS:C4692289

subject_name: erenumab-aooe


subject: UMLS:C4692289


subject: UMLS:C4692289


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab


subject: UNII:T4H8FMA7IM


subject: UNII:T4H8FMA7IM


subject: GTOPDB:13045

subject_name: rocatinlimab

object_name: atopic eczema


subject: CHEMBL.COMPOUND:CHEMBL4594567

subject_name: ROCATINLIMAB


subject: UMLS:C5669663

subject_name: Rocatinlimab


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: Hypercholesterolemia


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: periodontitis


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: UMLS:C1452745

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C1452745


subject: CHEBI:6801

subject_name: Metformin

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:6801

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:6801

object_name: pancreatic acinar cell carcinoma


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Treatment related acute myeloid leukaemia


subject: UMLS:C0003442

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C0003442

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C0003442

object_name: Refractory acute myeloid leukemia


subject: UMLS:C0003442

object_name: Acute lymphoid leukemia in remission


subject: UMLS:C0003442

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UMLS:C0003442

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UMLS:C0003442

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UMLS:C0003442

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:174615


subject: CHEBI:174615

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:174615

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:174615


subject: CHEBI:174615

object_name: chronic myelomonocytic leukemia


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:201431

object_name: myeloproliferative neoplasm


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031